fbpx

Search results

Author: InVivo Biosystems

Disease Modeling

Why C. elegans are ideal for Disease Modeling [Infographic]

Did you know C. elegans are an ideal model for disease modeling? It may seem unlikely that such a tiny animal would work well for modeling and studying human diseases, but we believe in their power and want you to as well, so we’ve outlined a few of their strengths so you can learn more about the benefits of using C. elegans for disease modeling.

Read More »
17 Minutes of Science

Seventeen Minutes of Science: Tiny Worms With a Big Impact; Using C. elegans for Toxicology Studies

Tune into 17 Minutes of Science where we discuss with a new guest each week how science and biotech is woven into their lives. This week, we are joined by Kyle Galford to discuss his recently published paper, The FDA-approved drugs ticlopidine, sertaconazole, and dexlansoprazole can cause morphological changes in C. elegans, and how C. elegans can be used in toxicology studies.

Read More »
17 Minutes of Science

Seventeen Minutes of Science: Helping PhD’s Launch Meaningful Careers Outside of Academia

Tune into 17 Minutes of Science where we discuss with a new guest each week how science and biotech is woven into their lives. This week, we are joined by Dr. Jennifer Polk who has worked as an academic, life, and career coach for graduate students and PhDs since 2013. She is the founder of From PhD to Life and will be discussing with us how she helps PhD’s launch meaningful careers outside of academia.

Read More »
17 Minutes of Science

Seventeen Minutes of Science: Biotechnology in the Time of COVID with Dr. Jeremy Levin

Tune into 17 Minutes of Science where we discuss with a new guest each week how science and biotech is woven into their lives. This week, we are joined by Dr. Jeremy Levin of Ovid Therapeutics and BIO to discuss his recent book, Biotechnology in the Time of COVID, and dig a bit deeper into the impact of the current coronavirus pandemic on biotech and biopharma, both in the short-term and the long-term.

Read More »
17 Minutes of Science

Seventeen Minutes of Science: From PharmD to Regulatory Writing

Tune into 17 Minutes of Science where we discuss with a new guest each week how science and biotech is woven into their lives. This week, we are joined by Divyanka Gupta, a regulatory writer at Ora, Inc. who joins us to discuss what it means to be a regulatory writer, landing a job in the midst of a pandemic, and career tips for job-hunters looking for unconventional science careers.

Read More »
17 Minutes of Science

Seventeen Minutes of Science: Engineering a Cure for Fragile X

Tune into 17 Minutes of Science where we discuss with a new guest each week how science and biotech is woven into their lives. This week, we are joined by Dave Bjork, the Director of Community Relations at FRAXA Research Foundation, the Founder of FRAXA Biotech Games, and a Patient Advocate to discuss Fragile X Syndrome and the progress being made towards a cure.

Read More »
17 Minutes of Science

Seventeen Minutes of Science: How Epidemiology is Related to Everything!

Tune into 17 Minutes of Science where we discuss with a new guest each week how science and biotech is woven into their lives. This week, we are joined by Diana Klatt, a sociobehavioral epidemiologist in New York City. Diana joins us to discuss what it means to be an epidemiologist, her work as a sociobehavioral epidemiologist, and how her field has been affected by the coronavirus pandemic.

Read More »
17 Minutes of Science

Seventeen Minutes of Science: Experiential Science Education For Children in the Age of COVID

Tune into 17 Minutes of Science where we discuss with a new guest each week how science and biotech is woven into their lives. This week, we are joined by Hannah Kistner, who through her involvement with the Santa Barbara Zoo’s education department and the California homeschool community has designed science curriculums for biology and conservation. She joins us to discuss more about these curriculums, share resources, and offer advice for parents and teachers who are having to do distanced learning due to COVID-19.

Read More »
17 Minutes of Science

Seventeen Minutes of Science: Dr. GPCR: Advancing GPCR Drug Discovery Through Collaboration

Tune into 17 Minutes of Science where we discuss with a new guest each week how science and biotech is woven into their lives. This week, we are joined by Dr. Yamina Berchiche to discuss more about the importance of GCPRs in drug discovery and her work with Dr. GPCR, from recognizing the need and founding the program only a few months ago to running the program and seeing the impact.

Read More »
CRISPR

What Can Zebrafish Tell us About CRISPR Off-Target Activity?

In 2017, a now-redacted paper published in Nature Methods claimed that CRISPR created hundreds of unintended mutations in mouse models, and that algorithms designed to detect those “off target effects” weren’t working. The news sent share prices of CRISPR-based companies plummeting, and created rumblings—even panic—among scientists and gene editing-watchers worldwide. How accurate was CRISPR-Cas9, after all?

Read More »